RIL
ACAD icon

Rothschild Investment LLC’s Acadia Pharmaceuticals ACAD Stock Holding History

Rothschild Investment LLC’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38K Sell
152
-63
-29% -$1.51K ﹤0.01% 2266
2025
Q4 		$5.74K Buy
215
+25
+13% +$597 ﹤0.01% 1818
2025
Q3 		$4.05K Sell
190
-20
-10% -$473 ﹤0.01% 1802
2025
Q2 		$4.53K Sell
210
-10
-5% -$186 ﹤0.01% 1564
2025
Q1 		$3.65K Buy
220
+50
+29% +$908 ﹤0.01% 1585
2024
Q4 		$3.12K Buy
170
+55
+48% +$888 ﹤0.01% 1550
2024
Q3 		$1.77K Buy
115
+75
+188% +$1.25K ﹤0.01% 1795
2024
Q2 		$650 Buy
40
+30
+300% +$484 ﹤0.01% 1868
2024
Q1 		$185 Buy
+10
New +$248 ﹤0.01% 1780

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return